Iran vs North Korea: Patent applications, residents
Patent applications, residents over time
- Iran
- North Korea
How they compare
Iran currently reports 8,314 against 6,936 in North Korea, a difference of 1,378.
That makes Iran's figure about 1.2 times North Korea's.
The two have swapped places 1 time across 14 shared years of data; in 2005 it was North Korea ahead.
Iran ranks 12th and North Korea ranks 13th of 139 countries.
Iran has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Iran | North Korea | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 8,213 | 6,753 | 1,460 | Iran |
| 2010s | 12,000 | 7,941 | 4,059 | Iran |
| 2020s | 9,120 | 6,897 | 2,223 | Iran |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher patent applications, residents, Iran or North Korea?
- Iran, at 8,314 against 6,936 in North Korea as of 2024.
- What is the difference in patent applications, residents between Iran and North Korea?
- 1,378, with Iran ahead.
- How many years of comparable data are there for Iran and North Korea?
- 14 years are reported by both, from 2005 to 2024.
- How do Iran and North Korea rank globally for patent applications, residents?
- Iran ranks 12th and North Korea ranks 13th of 139 countries.
- Where does this data come from?
- WIPO Patent Report: Statistics on Worldwide Patent Activity, World Intellectual Property Organization (WIPO), note: The International Bureau of WIPO assumes no responsibility with respect to the trans, published as Patent applications, residents. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Patent applications are worldwide patent applications filed through the Patent Cooperation Treaty procedure or with a national patent office for exclusive rights for an invention--a product or process that provides a new way of doing something or offers a new technical solution to a problem. A patent provides protection for the invention to the owner of the patent for a limited period, generally 20 years.